Literature DB >> 17620460

Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations.

Carlos S Restrepo1, Jorge A Carrillo, Santiago Martínez, Paulina Ojeda, Aura L Rivera, Ami Hatta.   

Abstract

Cocaine is the illicit drug whose abuse most often results in cardiopulmonary symptoms and emergency treatment. Habitual smoking of alkaloidal cocaine ("freebase," "crack") has replaced nasal insufflation as the most common method of abuse. Smoking of cocaine exposes the lung directly to the volatilized drug as well as to the other combustion products of the smoked mixture, thereby increasing the risk of adverse pulmonary effects. A wide variety of pulmonary complications including interstitial pneumonitis, fibrosis, pulmonary hypertension, alveolar hemorrhage, asthma exacerbation, barotrauma, thermal airway injury, hilar lymphadenopathies, and bullous emphysema may be associated with the inhalation of crack cocaine or of associated substances such as talc, silica, and lactose. Cocaine abuse represents one of the most serious medical and social problems of our time. Radiologists should be familiar with the various pleuropulmonary complications associated with the abuse of illicit drugs in general and of cocaine in particular to ensure correct diagnosis and appropriate treatment planning in patients with respiratory manifestations associated with such abuse. RSNA, 2007

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620460     DOI: 10.1148/rg.274065144

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  27 in total

1.  Cocaine-induced pulmonary changes: HRCT findings.

Authors:  Renata Rocha de Almeida; Gláucia Zanetti; Arthur Soares Souza; Luciana Soares de Souza; Jorge Luiz Pereira E Silva; Dante Luiz Escuissato; Klaus Loureiro Irion; Alexandre Dias Mançano; Luiz Felipe Nobre; Bruno Hochhegger; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2015 Jul-Aug       Impact factor: 2.624

2.  Reactive Oxygen Species/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Contributes to Cocaine-Mediated Alveolar Epithelial Barrier Damage.

Authors:  Lu Yang; Xufeng Chen; Samantha M Simet; Guoku Hu; Yu Cai; Fang Niu; Yeonhee Kook; Shilpa J Buch
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

3.  What does acute dyspnea hide?

Authors:  Giovanna Squiccimarro; Maria Carrabba; Cinzia Hu; Maria Domenica Cappellini; Giovanna Fabio
Journal:  Intern Emerg Med       Date:  2011-07-13       Impact factor: 3.397

4.  A severe complication of crack cocaine use.

Authors:  Gokul Vidyasankar; Carolina Souza; Chi Lai; Sunita Mulpuru
Journal:  Can Respir J       Date:  2015 Mar-Apr       Impact factor: 2.409

5.  Stimulants and Pulmonary Arterial Hypertension: An Update.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Adv Pulm Hypertens       Date:  2018

6.  Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers.

Authors:  Petal A H M Wijnen; Otto Bekers; Marjolein Drent
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

7.  Cocaine-Induced Bronchospasm Mimicking Acute Asthma Exacerbation.

Authors:  Christine Y Zhou; Melissa Ricker; Vikas Pathak
Journal:  Clin Med Res       Date:  2019-06

8.  Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction in a cocaine abuser patient.

Authors:  Mohammad Parsa Mahjoob; Isa Khaheshi; Koosha Paydary
Journal:  Heart Views       Date:  2014-07

9.  Smokers versus snorters: do treatment outcomes differ according to route of cocaine administration?

Authors:  Brian D Kiluk; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2013-12       Impact factor: 3.157

Review 10.  High-resolution computed tomographic findings of cocaine-induced pulmonary disease: a state of the art review.

Authors:  Renata Rocha de Almeida; Luciana Soares de Souza; Alexandre Dias Mançano; Arthur Soares Souza; Klaus Loureiro Irion; Luiz Felipe Nobre; Gláucia Zanetti; Bruno Hochhegger; Jorge Luiz Pereira e Silva; Edson Marchiori
Journal:  Lung       Date:  2014-01-16       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.